Monday, March 27th, 2017, 3:55 pm - 4:40 pm

Location: The Francis Crick Institute

With an expanding Alzheimer’s pipeline, design challenges continue to limit the flexibility of trial execution. Which emerging solutions (e.g. digital technologies, data sharing, patient recruitment, alternative endpoints) will transform cost, duration, or value generated from future Alzheimer’s trials?

Event

Session 6 – Implementing Novel Models in Alzheimer’s Trials: How Can We Transform the Cost-Benefit Equation for Trials?

Monday, March 27th, 2017, 3:55 pm - 4:40 pm

Location: The Francis Crick Institute

With an expanding Alzheimer’s pipeline, design challenges continue to limit the flexibility of trial execution. Which emerging solutions (e.g. digital technologies, data sharing, patient recruitment, alternative endpoints) will transform cost, duration, or value generated from future Alzheimer’s trials?